1. Home
  2. DRMA vs BACK Comparison

DRMA vs BACK Comparison

Compare DRMA & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • BACK
  • Stock Information
  • Founded
  • DRMA 2014
  • BACK 2000
  • Country
  • DRMA United States
  • BACK United States
  • Employees
  • DRMA N/A
  • BACK N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • BACK Medical Specialities
  • Sector
  • DRMA Health Care
  • BACK Health Care
  • Exchange
  • DRMA Nasdaq
  • BACK Nasdaq
  • Market Cap
  • DRMA 2.2M
  • BACK 2.2M
  • IPO Year
  • DRMA 2021
  • BACK 2019
  • Fundamental
  • Price
  • DRMA $1.06
  • BACK $1.10
  • Analyst Decision
  • DRMA Strong Buy
  • BACK
  • Analyst Count
  • DRMA 1
  • BACK 0
  • Target Price
  • DRMA $6.00
  • BACK N/A
  • AVG Volume (30 Days)
  • DRMA 588.9K
  • BACK 23.2K
  • Earning Date
  • DRMA 11-13-2024
  • BACK 12-31-2024
  • Dividend Yield
  • DRMA N/A
  • BACK N/A
  • EPS Growth
  • DRMA N/A
  • BACK N/A
  • EPS
  • DRMA N/A
  • BACK N/A
  • Revenue
  • DRMA N/A
  • BACK N/A
  • Revenue This Year
  • DRMA N/A
  • BACK N/A
  • Revenue Next Year
  • DRMA N/A
  • BACK N/A
  • P/E Ratio
  • DRMA N/A
  • BACK N/A
  • Revenue Growth
  • DRMA N/A
  • BACK N/A
  • 52 Week Low
  • DRMA $1.03
  • BACK $0.98
  • 52 Week High
  • DRMA $13.35
  • BACK $7.75
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 41.39
  • BACK 45.18
  • Support Level
  • DRMA $1.03
  • BACK $1.06
  • Resistance Level
  • DRMA $1.43
  • BACK $1.21
  • Average True Range (ATR)
  • DRMA 0.14
  • BACK 0.10
  • MACD
  • DRMA -0.01
  • BACK 0.01
  • Stochastic Oscillator
  • DRMA 11.90
  • BACK 29.17

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About BACK IMAC Holdings Inc.

IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.

Share on Social Networks: